Molecular portrait of hypoxia in breast cancer: a prognostic signature and novel HIF-regulated genes IC Ye, EJ Fertig, JW DiGiacomo, M Considine, I Godet, DM Gilkes Molecular Cancer Research 16 (12), 1889-1901, 2018 | 91 | 2018 |
Collective cancer cell invasion induced by coordinated contractile stresses AMJ Valencia, PH Wu, ON Yogurtcu, P Rao, J DiGiacomo, I Godet, L He, ... Oncotarget 6 (41), 43438, 2015 | 79 | 2015 |
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies JW DiGiacomo, DM Gilkes Targeted Oncology, 1-17, 2018 | 26 | 2018 |
Hypoxia alters the response to anti-EGFR therapy by regulating EGFR expression and downstream signaling in a DNA methylation–specific and HIF-dependent manner M Mamo, IC Ye, JW DiGiacomo, JY Park, B Downs, DM Gilkes Cancer research 80 (22), 4998-5010, 2020 | 25 | 2020 |
RhoB is regulated by hypoxia and modulates metastasis in breast cancer JA Ju, I Godet, JW DiGiacomo, DM Gilkes Cancer Reports 3 (1), e1164, 2020 | 24 | 2020 |
Extracellular matrix–bound fgf2 mediates estrogen receptor signaling and therapeutic response in breast cancer JW DiGiacomo, I Godet, M Trautmann-Rodriguez, DM Gilkes Molecular Cancer Research 19 (1), 136-149, 2021 | 21 | 2021 |
Therapeutic strategies to block the hypoxic response JW DiGiacomo, DM Gilkes Hypoxia and Cancer Metastasis, 141-157, 2019 | 10 | 2019 |
A software tool for the quantification of metastatic colony growth dynamics and size distributions in vitro and in vivo S Bhoyar, I Godet, JW DiGiacomo, DM Gilkes PloS one 13 (12), e0209591, 2018 | 5 | 2018 |
THE TUMOR MICROENVIRONMENT’S IMPACT ON BREAST CANCER PHENOTYPE AND PROGRESSION: THE EXTRACELLULAR MATRIX AND THE METASTATIC NICHE J DiGiacomo Johns Hopkins University, 2021 | | 2021 |
Extracellular matrix signaling modulates estrogen receptor activity in breast cancer JW DiGiacomo, I Godet, MT Rodriguez, IC Ye, DM Gilkes Cancer Research 79 (13_Supplement), 1010-1010, 2019 | | 2019 |